Spots Global Cancer Trial Database for chemotherapy induced nausea and vomiting
Every month we try and update this database with for chemotherapy induced nausea and vomiting cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone | NCT02532634 | Cancer Tumors | ramosetron, apr... palonosetron, a... | 19 Years - | Kangdong Sacred Heart Hospital | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years | NCT01596426 | Chemotherapy In... | Sancuso IV granisetron | 2 Years - 5 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin | NCT00430313 | Liver Cancer Liver Metastasi... | Electro-Stimula... Electro-Stimula... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting | NCT02787707 | Nausea Vomiting | Persumac lactose | 18 Years - 70 Years | Mashhad University of Medical Sciences | |
| Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide | NCT01450826 | Nausea Vomiting Glioma | aprepitant ondansetron | 18 Years - | Duke University | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years | NCT01596426 | Chemotherapy In... | Sancuso IV granisetron | 2 Years - 5 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting | NCT05792228 | Squamous Cell C... Chemotherapy In... | nurse-led stand... | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years | NCT01596413 | Chemotherapy In... | Sancuso IV granisetron | 6 Years - 12 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin | NCT00430313 | Liver Cancer Liver Metastasi... | Electro-Stimula... Electro-Stimula... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients | NCT04873284 | Chemotherapy In... Pediatric Cance... | fosaprepitant aprepitant Granisetron plu... | 2 Years - 12 Years | Shanghai Children's Medical Center | |
| Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide | NCT01450826 | Nausea Vomiting Glioma | aprepitant ondansetron | 18 Years - | Duke University | |
| A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting | NCT05792228 | Squamous Cell C... Chemotherapy In... | nurse-led stand... | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years | NCT01596400 | Chemotherapy In... | granisetron tra... Granisetron IV | 13 Years - 17 Years | Kyowa Kirin Pharmaceutical Development Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
